Amgen's Prolia hopes heighten on disappointing full-year revenues
26 January 2010
Christopher Spillane
Please Login to read the full article.
26 January 2010
Christopher Spillane
The arrival of Amgen's potential blockbuster Prolia (denosumab) could not be timelier after the company's full-year revenues contracted on disappointing product sales. 2009 revenues were down by 2% but the outlook is promising with growth expected to return this year.
The firm's...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
